Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)
Launched by DUKE UNIVERSITY · Mar 3, 2016
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this project is to implement a system of prospective, standardized data collection for all patients with cleft lip and/or palate (CL/P) treated by the cleft and craniofacial centers that participate in ACCQUIREnet.
Adoption of this prospective data-collection system has two principal goals:
1. To enable on-demand and scheduled review of cleft-care-related safety and outcomes data and team performance for the purpose of internal audits and continuous quality improvement; and
2. To permit participation in multi-site, collaborative quality-improvement projects and/or research ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Typical orofacial clefts, of which subtypes are:
- • Unilateral or bilateral cleft lip
- • Unilateral or bilateral cleft lip and alveolus
- • Unilateral or bilateral cleft lip and alveolus and palate
- • Unilateral or bilateral cleft lip and palate
- • Overt cleft palate
- • Occult cleft palate
- Exclusion Criteria:
- • Atypical (Tessier) facial clefts
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Maine, United States
Hollywood, Florida, United States
Gainesville, Florida, United States
Orlando, Florida, United States
Saint Petersburg, Florida, United States
Boston, Massachusetts, United States
Saint Louis, Missouri, United States
Durham, North Carolina, United States
Winston Salem, North Carolina, United States
Houston, Texas, United States
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Alexander C Allori, MD, MPH
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials